15th – 17th April, 2019 | London

Day One
TUESDAY, 16TH APRIL, 2019

Day Two
WEDNESDAY, APRIL 17, 2019

08.40
Chair’s Opening Remarks

  • Bryan McDowell Executive Director - Global Program Lead for Data & Digital , Novartis

Driving Patient-Centricity with Digital-Enabled Approaches

08.50
Patient-Focused Drug Development – Building Digital Innovation & Ecosystems in Clinical Research

  • Bryan McDowell Executive Director - Global Program Lead for Data & Digital , Novartis

Synopsis

  • What does patient-focused drug development look like?
  • Exploring digital and clinical innovation to change the paradigm of drug development and patient journey – what’s next?
  • Utilising information beyond clinical trials – complementing drug development & life cycles by redefining ‘Health Records’

09.20
‘IMPACCT’ Panel Discussion: The Patient – Driving Patient Centricity in Clinical Research

  • Caroline Feys Research & Development Operations Innovation Leader , Janssen Pharmaceuticals
  • Isabela Niculae Global Associate Director – Patient Recruitment & Retention Strategist , Biogen
  • Sheli Gupta President, European Operations , Hu-manity.co
  • Bryan McDowell Executive Director - Global Program Lead for Data & Digital , Novartis

Synopsis

  • Delving into patient-centric trials: transformation of trials is seen as key to patientcentric models, but are we focusing too much on other stakeholders (sponsor, site, CROs, etc,) and not enough on our primary ‘stakeholders’ – the patients?
  • Analysing how digital health technology generates increased patient engagement, retention, and compliance
  • Exploring the unique opportunity digital tools present for how clinical trials monitor, communicate and work alongside patients – the patient as a partner
  • Patient data ownership – integrating the voice of the patient and enabling their active and central participation in clinical innovation and digital transformation of healthcare
  • Giving patients control over their own data

10.05
Bringing a Hybrid Model to a Clinical Trial– How to Implement Study Visits That Are Truly Patient-Centric

Synopsis

  • What is the hybrid model and how are Sponsors and CRO customers responding?
  • Why is a hybrid model important to offer to patients?
  • Operationalizing this – the challenges. solutions and future direction

10.15
Morning Refreshments & Networking

11.00
Engaging Patient by Providing Access to Patient Data Access In Clinical Trials: From Concept To Implementation

  • Caroline Feys Research & Development Operations Innovation Leader , Janssen Pharmaceuticals

Synopsis

  • Providing access to patient data while in a study – a case-study
  • Overviewing the global implementation of data access through the Janssen Global Trial Community
  • Exploring how a consortium creates new opportunities and greater value by increasing speed of innovation, adoption and responsiveness to customers

11.30
Your Data, Your Property – Delving into Patient Data Ownership

  • Sheli Gupta President, European Operations , Hu-manity.co

Synopsis

  • Who owns patient data?
  • Using Blockchain to enable patient data ownership
  • Going further – compensation for ongoing use of patient data

12.00
Mastermind Session: Driving Digital Innovation Towards Truly Patient- Centric Clinical Studies

Synopsis

This session facilitates in-depth discussions among participants in an informal environment. After splitting into groups, participants will discuss key challenges and opportunities regarding the current landscape in mobile and digital-enable clinical research.

12.45
Lunch & Networking

Exploring the Scope of Mobile Health in Broader Healthcare Ecosystem Settings

13.45
Digital Biomarkers in Clinical Trials – Learnings & Prospects

Synopsis

  • Enabling the measurement of disease symptoms in home settings  with digital devices
  • Discussing whether clinical teams rightly worry whether patients would perform at-home assessments and perform them correctly
  • Demonstrating  that patients closely adhere to protocol and that at-home assessments relate to traditionally measured disease state, utilizing device data

14.15
Advancing Personalised Care & Access Models in Oncology Through Digital Health

Synopsis

  • Addressing how digital health approaches can advance personalised care
  • Highlighting findings from our digital Patient Monitoring project in cancer immunotherapy

14.45
Advancing Nutrition Research Studies with Novel Technologies

  • Florent Schäfer Clinical Affairs & Human Translational Research, Danone Research, Danone

Synopsis

  • Overviewing the main operational challenges for the conduct of nutrition clinical trials
  • Exploring opportunities for the use of digital markers in conventional nutrition clinical research
  • Presenting perspectives for the use of innovative data sources and designs beyond RCT

15.15
Chair’s Closing Remarks

  • Bryan McDowell Executive Director - Global Program Lead for Data & Digital , Novartis